Alessandro Morandi1,2, Giuseppe Bellelli3. 1. Department of Rehabilitation, Aged Care "Fondazione Camplani" Hospital, Via Aselli 14, 26100, Cremona, CR, Italy. morandi.alessandro@gmail.com. 2. Institute of Research and Parc Sanitari Pere Virgili, Barcelona, Spain. morandi.alessandro@gmail.com. 3. School of Medicine and Surgery, Acute Geriatric Unit, San Gerardo Hospital, University of Milano-Bicocca, Milan, Monza, Italy.
Abstract
PURPOSE: Delirium superimposed on dementia (DSD) is a frequent and growing emerging clinical challenge, given the increasing prevalence of dementia. METHODS: This narrative review focuses on and discusses the current knowledge on epidemiology, pathogenesis, diagnosis and management of DSD. RESULTS: There is a close interaction between delirium and dementia since dementia is a risk factor for delirium and delirium is a known risk factor for newly developed dementia or worsening of dementia. The occurrence of DSD causes adverse clinical outcomes. However, DSD is often under-recognized or is frequently considered as the regular course of dementia. Indeed, especially in the advance stages of dementia, DSD diagnosis is challenging since a clear distinction between symptoms attributable to delirium and to dementia is difficult. Given the importance of DSD, it is essential to educate health care providers on the best approach for delirium management and treatment. It is now well recognized that delirium can be prevented using multicomponent interventions carried out by a multidisciplinary team targeting predisposing and precipitating risk factors for delirium. On the contrary, antipsychotics should only be used in patients with severe distressing symptoms and whose behavior means their safety or the safety of those around them is compromised, given the harmful of these medications in patients with pre-existing dementia. CONCLUSIONS: It is essential to improve health care providers knowledge on DSD to improve the quality of care for an epidemiologically relevant though understudied population.
PURPOSE:Delirium superimposed on dementia (DSD) is a frequent and growing emerging clinical challenge, given the increasing prevalence of dementia. METHODS: This narrative review focuses on and discusses the current knowledge on epidemiology, pathogenesis, diagnosis and management of DSD. RESULTS: There is a close interaction between delirium and dementia since dementia is a risk factor for delirium and delirium is a known risk factor for newly developed dementia or worsening of dementia. The occurrence of DSD causes adverse clinical outcomes. However, DSD is often under-recognized or is frequently considered as the regular course of dementia. Indeed, especially in the advance stages of dementia, DSD diagnosis is challenging since a clear distinction between symptoms attributable to delirium and to dementia is difficult. Given the importance of DSD, it is essential to educate health care providers on the best approach for delirium management and treatment. It is now well recognized that delirium can be prevented using multicomponent interventions carried out by a multidisciplinary team targeting predisposing and precipitating risk factors for delirium. On the contrary, antipsychotics should only be used in patients with severe distressing symptoms and whose behavior means their safety or the safety of those around them is compromised, given the harmful of these medications in patients with pre-existing dementia. CONCLUSIONS: It is essential to improve health care providers knowledge on DSD to improve the quality of care for an epidemiologically relevant though understudied population.
Entities:
Keywords:
Delirium; Delirium superimposed on dementia; Dementia; Older
Authors: Alessandro Morandi; Elena Lucchi; Renato Turco; Sara Morghen; Fabio Guerini; Rossana Santi; Simona Gentile; David Meagher; Philippe Voyer; Donna Fick; Eva M Schmitt; Sharon K Inouye; Marco Trabucchi; Giuseppe Bellelli Journal: J Psychosom Res Date: 2015-08-08 Impact factor: 3.006
Authors: Elizabeth L Sampson; Martin R Blanchard; Louise Jones; Adrian Tookman; Michael King Journal: Br J Psychiatry Date: 2009-07 Impact factor: 9.319
Authors: Alessandro Morandi; Elena Lucchi; Renato Turco; Sara Morghen; Fabio Guerini; Rossana Santi; Simona Gentile; David Meagher; Philippe Voyer; Donna M Fick; Eva M Schmitt; Sharon K Inouye; Marco Trabucchi; Giuseppe Bellelli Journal: J Psychosom Res Date: 2015-08-09 Impact factor: 3.006
Authors: Daniel H J Davis; Graciela Muniz-Terrera; Hannah A D Keage; Blossom C M Stephan; Jane Fleming; Paul G Ince; Fiona E Matthews; Colm Cunningham; E Wesley Ely; Alasdair M J MacLullich; Carol Brayne Journal: JAMA Psychiatry Date: 2017-03-01 Impact factor: 21.596
Authors: Alessandro Morandi; Daniel Davis; Giuseppe Bellelli; Rakesh C Arora; Gideon A Caplan; Barbara Kamholz; Ann Kolanowski; Donna Marie Fick; Stefan Kreisel; Alasdair MacLullich; David Meagher; Karen Neufeld; Pratik P Pandharipande; Sarah Richardson; Arjen J C Slooter; John P Taylor; Christine Thomas; Zoë Tieges; Andrew Teodorczuk; Philippe Voyer; James L Rudolph Journal: J Am Med Dir Assoc Date: 2016-09-16 Impact factor: 4.669
Authors: Pia Urfer Dettwiler; Franziska Zúñiga; Stefanie Bachnick; Beatrice Gehri; Jos F M de Jonghe; Wolfgang Hasemann Journal: Eur Geriatr Med Date: 2022-02-10 Impact factor: 3.269